Medicine Man Technologies Inc (SHWZ)

[Future2016]

Stanley said Schwazze is coming off a strong first quarter where top and bottom lines beat his forecasts, and he said SHWZ is showing EBITDA margins that rank very high compared to the rest of the US cannabis space. The analyst said Schwazze is likely to counter ongoing price pressure by leveraging margin expansion opportunities like centralized buying and distribution, automated manufacturing and increased sales of house brands.

“Given SHWZ operates in two intensely competitive states that other operators have largely avoided/exited, we view Schwazze’s adjusted EBITDA margins as particularly impressive,” he said.

https://www.cantechletter.com/2023/06/schwazze-is-a-buy-in-cannabis-stocks-says-beacon/#